CPIX · Forms 3, 4, 5
Insider trades at CUMBERLAND PHARMACEUTICALS INC
No open-market insider buys or sells at CUMBERLAND PHARMACEUTICALS INC in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for CUMBERLAND PHARMACEUTICALS INC (CPIX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for CUMBERLAND PHARMACEUTICALS INC in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Todd M. Anthony | Vice Pres Organizational Dev | Options or other derivatives | Form 4 | ||||
| Chris T. Bitterman | Vice Pres Sales & Marketing | Options or other derivatives | Form 4 | ||||
| John M. Hamm | VP Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| James L Herman | VP and Chief Compliance Office | Options or other derivatives | Form 4 | ||||
| A J Kazimi | Chairman and CEO | Options or other derivatives | Form 4 | ||||
| Martin S Brown JR | Director | Award | 1,800 | $2.80 | $5K | Form 4 | |
| Joseph C Galante | Director | Award | 1,800 | $2.80 | $5K | Form 4 | |
| James Jones | Director | Award | 1,800 | $2.80 | $5K | Form 4 | |
| Kenneth Krogulski | Director | Award | 1,800 | $2.80 | $5K | Form 4 | |
| Kenneth Krogulski | Director | Award | 4,000 | $2.80 | $11K | Form 4 | |
| Caroline Young | Director | Award | 1,800 | $2.80 | $5K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.